Cargando…
The role of gonadotropin-releasing hormone agonists in female fertility preservation
Advances in anticancer treatments have resulted in increasing survival rates among cancer patients. Accordingly, the quality of life after treatment, particularly the preservation of fertility, has gradually emerged as an essential consideration. Cryopreservation of embryos or unfertilized oocytes h...
Autores principales: | Lee, Jae Hoon, Choi, Young Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Reproductive Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943347/ https://www.ncbi.nlm.nih.gov/pubmed/33648041 http://dx.doi.org/10.5653/cerm.2020.04049 |
Ejemplares similares
-
Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
por: Hong, Yeon Hee, et al.
Publicado: (2022) -
Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy
por: Massarotti, C., et al.
Publicado: (2023) -
Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013) -
Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2019) -
Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)